YCS21ยท AISFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Parallel BioS21Using the immune system to cure diseaseShared: ai-powered drug discovery, biotechActive
ResistanceBioW19We solve drug resistance for cancerShared: ai-powered drug discoveryInactive
Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: ai-powered drug discovery, biotechActive
Atlas DiscoveryS26AI-native pharma companyShared: ai-powered drug discovery, biotechnologyActive
Adjacent
Overlapping tags, a different niche.
Paceline BioF25Accelerating clinical ops for biotech & pharmaShared: ai-powered drug discovery, biotech, biotechnologyActive
Evolvere BioSciencesS24Making Next-Generation Antibiotics that Outpace Bacterial EvolutionShared: ai-powered drug discovery, biotech, biotechnologyActive
Dorian TherapeuticsS18New therapeutics to rejuvenate tissue and treat age-related diseasesShared: anti-aging, biotechAcquired
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, biotechnologyActive
Entelexo BiotherapeuticsW21Creating a New Class of Drugs to Address Incurable Autoimmune DiseasesShared: biotechActive
Also from S21 in AI
Batchmates in Summer 2021.
Output BiosciencesS21The foundation for the next era of biologyActive
AdaptyvS21We're building fully automated labs for protein engineeringActive
CellChorusS21The dynamic single-cell analysis companyActive
FitiaS21Automated Meal Planner & Nutrition TrackingActive
IntellectS21A modern-day mental healthcare company for global workforces.Active
MatrubialsS21Developing milk-inspired therapeutics for infectious diseasesActive
About SFA Therapeutics
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
Philadelphia, PA, USA
SFA Therapeutics: questions
Which YC batch was SFA Therapeutics in?
SFA Therapeutics was in Y Combinator's Summer 2021 batch (S21).
Is SFA Therapeutics still active?
Y Combinator lists SFA Therapeutics as active.
Where is SFA Therapeutics based?
SFA Therapeutics lists Philadelphia, PA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.